Luminex traded at $36.99 this Tuesday July 13th, decreasing $0 or 0 percent since the previous trading session. Looking back, over the last four weeks, Luminex lost 0.30 percent. Over the last 12 months, its price rose by 10.02 percent. Looking ahead, we forecast Luminex to be priced at 35.99 by the end of this quarter and at 33.17 in one year, according to Trading Economics global macro models projections and analysts expectations.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Luminex Corporation, is a technologies and applications company. The Company develops, manufactures and sell biological testing technologies and products with applications in the life sciences and diagnostics industries. The Company provides the industries with bioassays tests, which perform diagnostic tests and conduct life science research. The Company is organized into two reportable segments: Technology and Strategic Partnerships (TSP) segment, and the Assays and Related products (ARP) segment. Technology and Strategic Partnerships segment, offers Instruments, Consumables, and Software. The TSP Instruments include compact analyzers, general laboratory instruments and multiplexing analyzer. The TSP Consumables include types of microspheres. The TSP Software assists in laboratory workflow. Assays and Related products segment, offers Assay Product Families which comprises of chemical and biological reagents use bead technology to perform diagnostic and research assays on samples.